Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iguratimod Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117700340B reveals homogeneous catalytic route for Iguratimod intermediate. Enhances purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN112209859B reveals a safer CDI-based route for Iguratimod intermediates, offering high purity and reduced operational hazards for API manufacturing.